These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study. Richter JE; Long JF Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282 [TBL] [Abstract][Full Text] [Related]
6. Erosive esophagitis and NERD: Can we really classify patients with heartburn by endoscopic findings? Chey WD Clin Gastroenterol Hepatol; 2004 Aug; 2(8):654-5. PubMed ID: 15290656 [No Abstract] [Full Text] [Related]
7. Gastroesophageal reflux. A panel by correspondence. Arch Surg; 1974 Jan; 108(1):16-23. PubMed ID: 4808573 [No Abstract] [Full Text] [Related]
8. A comparative study of cisapride and ranitidine at controlling oesophageal acid exposure in erosive oesophagitis. Pouderoux P; Kahrilas PJ Aliment Pharmacol Ther; 1995 Dec; 9(6):661-6. PubMed ID: 8824654 [TBL] [Abstract][Full Text] [Related]
9. The effect of cisapride in patients with reflux esophagitis: an ambulatory esophageal manometry/pH-metry study. Paterson WG; Wang H; Beck IT Am J Gastroenterol; 1997 Feb; 92(2):226-30. PubMed ID: 9040196 [TBL] [Abstract][Full Text] [Related]
10. Cisapride in the treatment of gastro-oesophageal reflux disease. Robertson CS; Evans DF; Ledingham SJ; Atkinson M Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271 [TBL] [Abstract][Full Text] [Related]
11. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride]. Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622 [TBL] [Abstract][Full Text] [Related]
12. Cisapride for nocturnal heartburn. Med Lett Drugs Ther; 1994 Feb; 36(915):11-3. PubMed ID: 8283956 [No Abstract] [Full Text] [Related]
13. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422 [TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of reflux disease]. Koelz HR; Siewert JR; Blum AL Dtsch Med Wochenschr; 1986 Jan; 111(3):102-5. PubMed ID: 3940842 [No Abstract] [Full Text] [Related]
18. Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease. Gardner JD; Rodriguez-Stanley S; Robinson M; Miner PB Aliment Pharmacol Ther; 2002 Oct; 16(10):1819-29. PubMed ID: 12269977 [TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled trial of cisapride in postgastrectomy patients with duodenogastroesophageal reflux. Vaezi MF; Sears R; Richter JE Dig Dis Sci; 1996 Apr; 41(4):754-63. PubMed ID: 8674397 [TBL] [Abstract][Full Text] [Related]
20. Predictive value of esophageal manometry and gastroesophageal pH monitoring for responsiveness of reflux disease to medical therapy in children. Cucchiara S; Campanozzi A; Greco L; Franco MT; Emiliano M; Alfieri E; Calabrese F; Numeroso V Am J Gastroenterol; 1996 Apr; 91(4):680-5. PubMed ID: 8677928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]